DeepMed Research

Tongji University Tongji Hospital of(Formerly Ganquan Hospital)

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Low-dose Chemotherapy Combine With Tyrosine Kinase Inhibitor to Treat ph+ Acute Lymphoblastic Leukemia Patients

Phase 4

Conditions: ph+ Acute Lymphoblastic Leukemia

Interventions: Drug: Dasatinib
Drug: prednisone
Drug: dexamethasone
Drug: methotrexate

First Posted Date: 2016-02-24

Last Posted Date: 2016-02-24

Lead Sponsor: Tongji Hospital

Target Recruit Count: 40

Registration Number: NCT02690922

Locations: 🇨🇳
Tongji hospital, Wuhan, Hubei, China

Dose-effect Relationship of Rt-PA on ICH Evacuation

Phase 2

Conditions: Hypertensive Intracerebral Hemorrhage

Interventions: Device: YL-1 type of intracranial hematoma puncture needle
Drug: rt-PA

First Posted Date: 2015-06-16

Last Posted Date: 2015-06-16

Lead Sponsor: Tongji Hospital

Target Recruit Count: 108

Registration Number: NCT02472574

Locations: 🇨🇳
Tongji Hospital, Wuhan, Hubei, China

Combination Therapy With Interferon Plus Interleukin 2 and Hepatitis B Vaccine in Chronic Hepatitis B Patients

Phase 4

Completed

Conditions: Hepatitis B, Chronic

Interventions: Drug: Entecavir
Drug: Interferon alfa-2b
Drug: Interleukin 2
Drug: Hepatitis B Vaccine

First Posted Date: 2015-02-10

Last Posted Date: 2018-05-09

Lead Sponsor: Tongji Hospital

Target Recruit Count: 94

Registration Number: NCT02360592

Locations: 🇨🇳
Anhui Provincial Hospital, Hefei, Anhui, China
🇨🇳
BeiJing YouAn Hospital, Capital Medical University, Beijing, Beijing, China
🇨🇳
First Hospital, Beijing University, Beijing, Beijing, China

and more 9 locations

Fast-track Surgery in the Treatment of Hirschsprung's Disease

Not Applicable

Conditions: Surgery

Interventions: Drug: probiotics
Drug: placebo

First Posted Date: 2015-01-29

Last Posted Date: 2015-01-29

Lead Sponsor: Tongji Hospital

Target Recruit Count: 100

Registration Number: NCT02350088

Locations: 🇨🇳
Tongji Hospital, Wuhan, Hubei, China

The Study of Functional Magnetic Resonance Imaging in Abdominal and Pelvic Diseases

Conditions: Pelvic Diseases
Abdominal Diseases

First Posted Date: 2015-01-14

Last Posted Date: 2018-01-17

Lead Sponsor: Tongji Hospital

Target Recruit Count: 1000

Registration Number: NCT02337777

Locations: 🇨🇳
Tongji Hospital affiliated to Tongji Medical college of Huazhong Universitity of Science and Technology, WuHan, Hubei, China

A Prospective Clinical Trial in Chronic Hepatitis B Patients NAs (Nucleotides or Nucleosides) Experienced (Anchor Study)

Phase 3

Conditions: Hepatitis B, Chronic

Interventions: Drug: Y peginterferon alfa-2b
Drug: Entecavir and or adefovir dipivoxil
Drug: Granulocyte-macrophage colony stimulating factor

First Posted Date: 2014-12-30

Last Posted Date: 2016-08-15

Lead Sponsor: Tongji Hospital

Target Recruit Count: 300

Registration Number: NCT02327416

Locations: 🇨🇳
Beijing Youan Hospital, Beijing, Beijing, China
🇨🇳
Tongji Hospital, Wuhan, Hubei, China
🇨🇳
Xiangya Hospital, Central South University, Changsha, Hunan, China

and more 1 locations

Anal Dilatation for Infants and Children With Constipation

Not Applicable

Conditions: Constipation

Interventions: Drug: Lactulose

First Posted Date: 2014-10-03

Last Posted Date: 2014-10-03

Lead Sponsor: Tongji Hospital

Target Recruit Count: 100

Registration Number: NCT02255747

Locations: 🇨🇳
Tongji Hospital, Wuhan, Hubei, China

Comparison of Circular(Soave) and Heart-shaped Anastomosis in Hirschsprung's Disease

Not Applicable

Active, not recruiting

Conditions: Constipation

Interventions: Procedure: Heart-shape anastomosis
Procedure: Soave anastomosis

First Posted Date: 2014-09-09

Last Posted Date: 2025-05-21

Lead Sponsor: Tongji Hospital

Target Recruit Count: 177

Registration Number: NCT02234219

Locations: 🇨🇳
Tongji Hospital, Wuhan, Hubei, China

A New Scoring System Improves Diagnostic Accuracy of Intestinal Dysganglionosis --a Prospective Study

Not Applicable

Conditions: Hirschsprung Disease

Interventions: Drug: high dose lactulose
Behavioral: conservative treatment
Drug: paraffin oil

First Posted Date: 2014-08-15

Last Posted Date: 2014-10-28

Lead Sponsor: Tongji Hospital

Target Recruit Count: 80

Registration Number: NCT02216994

Locations: 🇨🇳
Tongji Hospital, Wuhan, Hubei, China

A Trial on Treatments of Hirschsprung Allied Disease

Not Applicable

Recruiting

Conditions: Complications of Treatment
Complication of Surgical Procedure
Megacolon, Not Hirschsprung

Interventions: Behavioral: conservative
Procedure: operative

First Posted Date: 2014-08-08

Last Posted Date: 2020-03-11

Lead Sponsor: Tongji Hospital

Target Recruit Count: 50

Registration Number: NCT02212054

Locations: 🇨🇳
Department of Pediatric Surgery, Wuhan, Hubei, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy